SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2507072956> ?p ?o ?g. }

Showing items 1 to 100 of ±174 with 100 items per page.

W2507072956 abstract "Introduction Studies have shown that transgender women (TGW) are disproportionately affected by HIV, with an estimated HIV prevalence of 19.1% among TGW worldwide. After receiving a diagnosis, HIV‐positive TGW have challenges accessing effective HIV treatment, as demonstrated by lower rates of virologic suppression and higher HIV‐related mortality. These adverse HIV outcomes have been attributed to the multiple sociocultural and structural barriers that negatively affect their engagement within the HIV care continuum. Guidelines for feminizing hormonal therapy among TGW recommend combinations of oestrogens and androgen blockers. Pharmacokinetic studies have shown that certain antiretroviral therapy (ART) agents, such as protease inhibitors (PIs), non‐nucleoside reverse transcriptase inhibitors (NNRTIs) and cobicistat, interact with ethinyl estradiol, the key oestrogen component of oral contraceptives (OCPs). The goal of this article is to provide an overview of hormonal regimens used by TGW, to summarize the known drug‐drug interactions (DDIs) between feminizing hormonal regimens and ART, and to provide clinical care recommendations. Methods The authors identified English language articles examining DDIs between oestrogen therapy, androgen blockers and ART published between 1995 and 2015 using PubMed, Cumulative Index to Nursing and Allied Health Literature and EBSCOhost. Results and Discussion Published articles predominantly addressed interactions between ethinyl estradiol and NNRTIs and PIs. No studies examined interactions between ART and the types and doses of oestrogens found in feminizing regimens. DDIs that may have the potential to result in loss of virologic suppression included ethinyl estradiol and amprenavir, unboosted fosamprenavir and stavudine. No clinically significant DDIs were noted with other anti‐retroviral agents or androgen blockers Conclusions There are insufficient data to address DDIs between ART and feminizing hormone regimens used by TGW. There is an urgent need for further research in this area, specifically pharmacokinetic studies to study the direction and degree of interactions between oral, injectable and transdermal estradiol and ART. Clinicians need to be vigilant about possible interactions and monitor hormone levels if concerns arise. More research is also needed on the provision of hormone therapy and gender‐affirming care on the long‐term health outcomes of HIV‐positive TGW." @default.
W2507072956 created "2016-08-23" @default.
W2507072956 creator A5008027144 @default.
W2507072956 creator A5012331999 @default.
W2507072956 creator A5073706410 @default.
W2507072956 date "2016-07-01" @default.
W2507072956 modified "2023-10-15" @default.
W2507072956 title "Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices" @default.
W2507072956 cites W1460245367 @default.
W2507072956 cites W1479924026 @default.
W2507072956 cites W1543489987 @default.
W2507072956 cites W1550070317 @default.
W2507072956 cites W1566726772 @default.
W2507072956 cites W1593565221 @default.
W2507072956 cites W180745073 @default.
W2507072956 cites W1841210688 @default.
W2507072956 cites W1934058713 @default.
W2507072956 cites W1964587597 @default.
W2507072956 cites W1964605733 @default.
W2507072956 cites W1968894580 @default.
W2507072956 cites W1971185957 @default.
W2507072956 cites W1973797603 @default.
W2507072956 cites W1973969725 @default.
W2507072956 cites W1980390609 @default.
W2507072956 cites W1981244456 @default.
W2507072956 cites W1982559953 @default.
W2507072956 cites W1983723007 @default.
W2507072956 cites W1987404283 @default.
W2507072956 cites W1992202990 @default.
W2507072956 cites W1994036015 @default.
W2507072956 cites W1996115562 @default.
W2507072956 cites W1998302567 @default.
W2507072956 cites W2000836832 @default.
W2507072956 cites W2001401927 @default.
W2507072956 cites W2005293828 @default.
W2507072956 cites W2009747821 @default.
W2507072956 cites W2010196839 @default.
W2507072956 cites W2012585252 @default.
W2507072956 cites W2013417284 @default.
W2507072956 cites W2013641871 @default.
W2507072956 cites W2014550364 @default.
W2507072956 cites W2023965170 @default.
W2507072956 cites W2027772619 @default.
W2507072956 cites W2030973274 @default.
W2507072956 cites W2032042459 @default.
W2507072956 cites W2032840172 @default.
W2507072956 cites W2034556500 @default.
W2507072956 cites W2035377904 @default.
W2507072956 cites W2038342993 @default.
W2507072956 cites W2050840945 @default.
W2507072956 cites W2051525912 @default.
W2507072956 cites W2064896399 @default.
W2507072956 cites W2066891494 @default.
W2507072956 cites W2068304604 @default.
W2507072956 cites W2069134864 @default.
W2507072956 cites W2071175698 @default.
W2507072956 cites W2072662024 @default.
W2507072956 cites W2080629272 @default.
W2507072956 cites W2080807877 @default.
W2507072956 cites W2085017024 @default.
W2507072956 cites W2088761302 @default.
W2507072956 cites W2089407653 @default.
W2507072956 cites W2090366088 @default.
W2507072956 cites W2090609682 @default.
W2507072956 cites W2093647119 @default.
W2507072956 cites W2098935287 @default.
W2507072956 cites W2107694591 @default.
W2507072956 cites W2115046127 @default.
W2507072956 cites W2115325589 @default.
W2507072956 cites W2116531236 @default.
W2507072956 cites W2120675005 @default.
W2507072956 cites W2121261576 @default.
W2507072956 cites W2128273706 @default.
W2507072956 cites W2133001403 @default.
W2507072956 cites W2134541671 @default.
W2507072956 cites W2135397849 @default.
W2507072956 cites W2137959413 @default.
W2507072956 cites W2141993490 @default.
W2507072956 cites W2142816214 @default.
W2507072956 cites W2144509036 @default.
W2507072956 cites W2148911925 @default.
W2507072956 cites W2151925148 @default.
W2507072956 cites W2153371068 @default.
W2507072956 cites W2154354745 @default.
W2507072956 cites W2157691983 @default.
W2507072956 cites W2163489043 @default.
W2507072956 cites W2164745264 @default.
W2507072956 cites W2165873164 @default.
W2507072956 cites W2166539756 @default.
W2507072956 cites W2167044266 @default.
W2507072956 cites W2171513312 @default.
W2507072956 cites W2172850797 @default.
W2507072956 cites W2297546177 @default.
W2507072956 cites W4229805333 @default.
W2507072956 cites W4240243247 @default.
W2507072956 doi "https://doi.org/10.7448/ias.19.3.20810" @default.
W2507072956 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4949308" @default.
W2507072956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27431475" @default.
W2507072956 hasPublicationYear "2016" @default.
W2507072956 type Work @default.